Eleanor PikeAssociateGreenberg Traurig, LLPWebsitewww.gtlaw.comOrganization ProfileFull ProfileConnectEmail+44 (0) 203.349.8700 Professional Biography Eleanor Pike is a member of the Litigation Practice in Greenberg Traurig's London office. She focuses her practice on complex commercial disputes, white collar crime and regulatory investigations. More Legal and Business Bylines From Eleanor Pike Update: UK Bans Exports of UK Professional Services to Russia and Includes Evraz plc on the UK Sanctions List - (Posted On Saturday, May 07, 2022) The UK Payment Systems Regulator’s First Five-Year Strategy Plan - (Posted On Monday, January 31, 2022) Current Legal Analysis FTC Surveillance Pricing Study Uncovers Personal Data Used to Set Individualized Consumer Prices by: Richard B. Newman DOL Clarifies That Managers and Supervisors Can’t Wear Two Hats When It Comes to Tips by: Victoria L. Vish NLRB GC Issues Memo on Harmonizing NLRA and EEO Laws by: Jennifer Betts , Thomas M. Stanek DOL Releases Final Rule for Self-Correction Under the Voluntary Fiduciary Compliance Program by: Katrina M. Clingerman , David S. Rosner CFPB Orders Credit Reporting Agency to Pay $15 Million for Mishandling Consumer Disputes by: A.J. S. Dhaliwal , Mehul N. Madia CFPB Proposes Roadmap For States to Continue Regulatory Activity by: A.J. S. Dhaliwal , Mehul N. Madia Trade Group Calls for Clarity on Ohio Fintech Guidance by: A.J. S. Dhaliwal , Mehul N. Madia Lead Generation One-to-One TCPA Consent Rule and Marketing Contract Considerations by: Richard B. Newman Upcoming Events Jan 21 2025 International Privacy & Cybersecurity Legal Update Jan 21 2025 U.S. Data Privacy & Cybersecurity Law Update Jan 21 2025 The Ethical Issues Involved with Creating a Data Protection Impact Assessment (DPIA) Jan 21 2025 U.S. Regulatory Investigations for Data Privacy and Cybersecurity Jan 22 2025 Employee Activism and the Issues It Can Create Jan 22 2025 The SEC under President Trump: A Preview Jan 22 2025 Transgender Employees and Related Issues in the Workplace Jan 28 2025 Antibody Drug Conjugates Keep Growing: What You Need to Know Print